Editor
The U.S. Drug Enforcement Agency and Health and Human Services announced the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, meant to prevent some patients from losing access to their telehealth-prescribed medications.
The agencies also said they would continue to develop the final rule governing the virtual prescribing of controlled substances in the post-pandemic era to be…
